Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer
Status: SUSPENDED
Study type: INTERVENTIONAL
Conditions: Fasting Mimicking Diet|HER2-negative Breast Cancer|Hormone Receptor-positive Breast Cancer|Pathological Complete Response|Objective Response Rate|Neoadjuvant Chemotherapy
Interventions: OTHER: Fasting Mimicking diet program
Sponsor: Leiden University Medical Center
Collaborators: The Netherlands Cancer Institute|Borstkanker Onderzoek Groep|Comprehensive Cancer Centre The Netherlands|Koningin Wilhelmina Fonds|World Cancer Research Fund International|L-Nutra Inc